Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Good
|
New words:
Appendix, Bregman, Buchbinder, correct, emerging, error, Glenmark, inadvertently, inclusion, Junior, Kenneth, Lannett, Lincoln, Linkbase, LLP, Marc, Nostrum, omitted, OTCQB, Park, Plassche, Reddy, Schema, Smith, SunGen, Taxonomy, Trimipramine, Tunick, typographical, USA
Removed:
affiliate, attached, based, board, chairman, computed, conclusive, consolidated, copy, cover, deemed, delinquent, determination, determining, expressly, greater, hereto, iii, including, Index, IRS, knowledge, listed, necessarily, Nox, occurring, page, posted, practical, President, read, schedule, site, Treasurer, voting, Web, year, Yesx
Filing tables
Filing exhibits
Associated ELTP transcripts
ELTP similar filings
Filing view
External links
Exhibit 31.1
CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER
I, Nasrat Hakim, certify that:
1. | I have reviewed this Amendment No. 1 to the Annual Form on Form 10-K of Elite Pharmaceuticals, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: June 22, 2021 | /s/ Nasrat Hakim |
Nasrat Hakim Chief Executive Officer, President and Chairman of the Board of Directors (Principal Executive Officer) |